Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Change in Account Payables (2023 - 2025)

Guardian Pharmacy Services' Change in Account Payables history spans 3 years, with the latest figure at -$4.8 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 411.85% year-over-year to -$4.8 million; the TTM value through Dec 2025 reached $16.4 million, up 23.95%, while the annual FY2025 figure was $16.4 million, 23.95% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$4.8 million at Guardian Pharmacy Services, down from $17.4 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $17.4 million in Q3 2025 and bottomed at -$4.8 million in Q4 2025.
  • The 3-year median for Change in Account Payables is $1.9 million (2025), against an average of $2.9 million.
  • The largest YoY upside for Change in Account Payables was 516.7% in 2025 against a maximum downside of 411.85% in 2025.
  • A 3-year view of Change in Account Payables shows it stood at -$3.9 million in 2023, then skyrocketed by 76.31% to -$928000.0 in 2024, then plummeted by 411.85% to -$4.8 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Change in Account Payables are -$4.8 million (Q4 2025), $17.4 million (Q3 2025), and $1.9 million (Q2 2025).